Gilenya (fingolimod)

pCPA File Number: 20787

Negotiation Status:

Concluded with an LOI

Indication(s):

Multiple Sclerosis

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

SR0228-000

pCPA Engagement Letter Issued:

2012-07-01

Negotiation Process Concluded:

2013-03-04